Incyte Corporation beat EPS estimates 69% of the time across 16 reported quarters (11 beats, 5 misses), averaging +13.2% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $1.76 | $2.80 | +59.1% | Beat | Q2 FY26 call |
| Q1 FY26 | $1.14 | $1.55 | +36.0% | Beat | |
| Q3 FY25 | $1.38 | $2.03 | +47.1% | Beat | |
| Q2 FY25 | $1.14 | $1.31 | +14.9% | Beat | Q2 FY25 call |
| Q1 FY25 | $0.75 | $0.89 | +18.7% | Beat | |
| Q4 FY24 | $1.29 | $1.09 | -15.5% | Miss | |
| Q3 FY24 | $0.88 | $0.73 | -17.1% | Miss | |
| Q2 FY24 | not reported | $-2.03 | not reported | not reported | |
| Q1 FY24 | $0.69 | $0.38 | -44.9% | Miss | |
| Q4 FY23 | $1.04 | $0.82 | -21.1% | Miss | |
| Q3 FY23 | $0.91 | $0.91 | +0.0% | Beat | |
| Q2 FY23 | $0.69 | $0.77 | +11.6% | Beat |
Back to INCY overview · INCY holders · INCY KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.